Q2 2022 Holdings
Filed 2022-08-15 | 47 holdings | $40.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Codexis Inc(CDXS) | COM | 192005106 | $13.5M | 1,288,450 | 33.3% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $12.5M | 671,300 | 30.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $11.9M | 302,500 | 29.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.4M | 90,000 | 6.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $24.3K | 3,332,732 | 0.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $24.0K | 5,974,800 | 0.1% |
| Tela BIO Inc(TELA) | COM | 872381108 | $11.5K | 1,643,367 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $8.9K | 2,684,167 | 0.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $8.3K | 4,125,322 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $7.9K | 814,250 | 0.0% |
| Merus N.V. | COM | N5749R100 | $7.7K | 338,000 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $7.6K | 276,000 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $6.7K | 590,000 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $6.5K | 2,462,500 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $5.9K | 263,050 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CLASS A | 75615P103 | $5.6K | 183,750 | 0.0% |
| Cutera(CUTREUR) | COM | 232109108 | $5.5K | 147,700 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $4.8K | 1,047,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.1K | 190,000 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $3.9K | 2,099,971 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $3.6K | 451,400 | 0.0% |
| 908 Devices Inc(MASS) | COM | 65443P102 | $3.4K | 166,406 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $3.0K | 1,430,000 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $2.7K | 3,247,180 | 0.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $2.3K | 521,500 | 0.0% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $2.3K | 325,000 | 0.0% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $2.1K | 2,740,000 | 0.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $2.0K | 238,670 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA4EUR) | CLASS A SHARES | 37611X100 | $1.9K | 815,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $1.8K | 1,590,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $1.8K | 932,814 | 0.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $1.7K | 763,075 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $1.5K | 362,000 | 0.0% |
| Modular Medical Inc(MODD) | COM NEW | 60785L207 | $1.4K | 275,422 | 0.0% |
| Impel Pharmaceuticals Inc | COM | 45258K109 | $1.3K | 144,642 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $1.3K | 460,000 | 0.0% |
| Journey Medicine Corp(DERM) | COM | 48115J109 | $919 | 245,733 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $628 | 610,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $614 | 208,300 | 0.0% |
| Neuropace Inc(NPCE) | COM | 641288105 | $446 | 90,100 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $404 | 58,700 | 0.0% |
| Optinose Inc | COM | 68404V100 | $333 | 90,970 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $333 | 68,900 | 0.0% |
| Avalo Therapeutics Inc | COM | 05338F108 | $225 | 450,000 | 0.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $179 | 32,300 | 0.0% |
| Lumos Pharma Inc | COM | 55028X109 | $166 | 21,520 | 0.0% |
| Biolinerx LTD | SPONSORED ADS | 09071M205 | $21 | 16,667 | 0.0% |